Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalyst Pharmaceutical Partners, Inc. (CPRX)  
$16.17 0.06 (0.37%) as of 4:30 Fri 5/31


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 103,650,000
Market Cap: 1.68(B)
Last Volume: 666,431 Avg Vol: 1,675,439
52 Week Range: $11.54 - $17.29
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  604
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 50,000 304,000 304,000 4,203,516
Total Sell Value $803,000 $4,338,050 $4,338,050 $62,649,148
Total People Sold 2 6 6 12
Total Sell Transactions 2 8 8 52
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 434
  Page 13 of 18  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Muth David D Exec. V.P., Corp. Development   •       –      –    2014-10-03 4 B $2.65 $26,500 D/D 10,000 20,000 2.74     -
   Huckel Hubert E Md Director   –       •      –    2014-10-02 4 D $0.00 $0 D/D (9,964) 1,324,170     -
   Huckel Hubert E Md Director   –       •      –    2014-10-02 4 OE $0.90 $27,000 D/D 30,000 1,334,134     -
   Coelho Philip H Director   –       •      –    2014-10-02 4 D $0.00 $0 D/D (9,964) 131,672     -
   Coelho Philip H Director   –       •      –    2014-10-02 4 OE $0.90 $18,032 D/D 20,036 141,636     -
   Miller Steve Chief Operating Officer   •       –      –    2014-10-02 4 OE $0.90 $157,500 D/D 175,000 389,754     -
   O'keeffe Charles B Director   –       •      –    2014-10-02 4 OE $0.90 $94,500 D/D 105,000 297,126     -
   Mcenany Patrick J President and CEO   •       •      –    2014-10-02 4 OE $0.90 $135,000 D/D 150,000 3,920,918     -
   Grande Alicia VP, Treasurer and CFO   •       –      –    2014-10-02 4 OE $0.90 $81,000 D/D 90,000 156,346     -
   Muth David D Exec. V.P., Corp. DevelopmentO   •       –      –    2014-08-28 3 IO $0.00 $0 D/D 0 10,000     -
   Miller Steve Chief Operating Officer   •       –      –    2014-06-04 4 B $2.17 $216,990 D/D 100,000 214,754 2.74     -
   Mcenany Patrick J President and CEO   •       •      –    2014-05-21 4 B $1.89 $47,225 D/D 25,000 3,656,247 2.81     -
   O'keeffe Charles B Director   –       •      –    2014-05-19 4 B $1.83 $18,291 D/D 10,000 192,126 2.39     -
   O'keeffe Charles B Director   –       •      –    2014-04-16 4 B $2.02 $10,100 D/D 5,000 182,126 2.39     -
   Mcenany Patrick J President and CEO   •       •      –    2014-02-07 4 B $1.82 $45,500 D/D 25,000 3,631,247 2.81     -
   O'keeffe Charles B Director   –       •      –    2014-02-05 4 B $1.81 $18,099 D/D 10,000 177,126 2.39     -
   Tierney David S Director   –       •      –    2013-10-23 4 B $2.03 $16,240 D/D 8,000 213,401 2.39     -
   Mcenany Patrick J President and CEO   •       •      –    2013-10-21 4 B $1.59 $79,730 D/D 50,000 3,606,247 2.81     -
   O'keeffe Charles B Director   –       •      –    2013-10-21 4 B $1.84 $18,392 D/D 10,000 167,126 2.39     -
   Mcenany Patrick J President and CEO   •       •      –    2013-02-19 4 B $0.46 $23,000 D/D 50,000 3,556,247 2.81     -
   Mcenany Patrick J President and CEO   •       •      –    2012-12-17 4 B $0.45 $44,500 D/D 100,000 3,449,997 2.81     -
   Biomarin Pharmaceutical Inc 10% Owner   –       –       •   2012-12-08 4 B $0.75 $3,750,000 D/D 5,000,000 6,666,667 2.45     -
   Coelho Philip H Director   –       •      –    2012-11-15 4 B $0.41 $9,857 I/I 24,000 24,000 2.1     -
   O'keeffe Charles B Director   –       •      –    2012-11-15 4 B $0.42 $10,475 D/D 25,000 157,126 2.39     -
   Mcenany Patrick J President and CEO   •       •       •   2012-11-15 4 B $0.42 $42,010 D/D 100,000 3,349,997 3.23     -
  434 Records found
  Previous  10  11  12  13  14  15  16  17  18   
  Page 13 of 18
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us